Lu Lv

1.2k citations
24 papers · 887 indexed · 1 hit paper · h-index 12
Topics
Protein Degradation and Inhibitors (4 papers)RNA Interference and Gene Delivery (3 papers)Ubiquitin and proteasome pathways (3 papers)

In The Last Decade

Lu Lv

24 papers receiving 879 citations

Hit Papers

Clostridium butyricum and Its Derived Extracellular Vesic...202220262023202420224080120

Peers

Lu Lv
Comparison fields: 5 of 101
  • Molecular Biology 621
  • Plant Science 184
  • Oncology 101
  • Pollution 84
  • Genetics 82
Replace Cheol‐Won Yun with:
Cheol‐Won Yun South Korea
Amit Kumar Yadav India
Xiaolei Wei China
Fenglong Wang China
Évelyne Turlin France
Huihui Du China
Meirong Zhang China
Yun‐Yun Zeng China
Eduardo Callegari United States
Lu Lv relative to Cheol‐Won Yun South Korea Cheol‐Won Yun's profile →
Citations per field
00.5×4.9×
Cheol‐Won Yun · 1×
Citations per year

Countries citing papers authored by Lu Lv

Since Specialization
Citations

This map shows the geographic impact of Lu Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Lv more than expected).

Fields of papers citing papers by Lu Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lu Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Lv. The network helps show where Lu Lv may publish in the future.

Co-authorship network of co-authors of Lu Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Lu Lv. A scholar is included among the top collaborators of Lu Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lu Lv. Lu Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 4
4 3
5 2
6 56
7 13
8 6
9 4
10 8
11 26
12
Clostridium butyricum and Its Derived Extracellular Vesicles Modulate Gut Homeostasis and Ameliorate Acute Experimental Colitisbreakdown →
140
13 6
14 117
15 81
16 26
17 29
18 6
19 17
20 124

About Lu Lv

Lu Lv is a scholar working on Molecular Biology, Immunology and Cancer Research, having authored 24 papers that have together received 887 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), RNA Interference and Gene Delivery (3 papers) and Ubiquitin and proteasome pathways (3 papers). The work is most often cited by research in Molecular Biology (621 citations), Pollution (84 citations) and Health, Toxicology and Mutagenesis (81 citations). Lu Lv has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xinju Liu, Shenggan Wu, Xueping Zhao, Jinhua Jiang, Liezhong Chen, Yingping Xiao, Wentao Lyu, Hua Yang, Lingyan Ma and Qiang Wang. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026